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Abstract 17 
Verotoxigenic E. coli (VTEC) belong to a diverse range of serotypes. Serotypes O157 and 18 
O26 are predominately identified in VTEC-associated disease in Europe, however due to 19 
difficulty in detection little is known about the epidemiology of non-O157 serotypes. This 20 
study reports the identification of 7 VTEC serotypes from cattle faeces and soil. Cattle faeces 21 
samples (n=128) were taken from animals in 6 different farms, with soil samples (n=20) 22 
obtained from one farm. After sample incubation in modified tryptone soy broth (mTSB) 23 
supplemented with streptomycin sulphate samples were plated onto sorbitol MacConkey 24 
(SMAC) also supplemented with streptomycin sulphate. Bacteria detected on the plates were 25 
subjected to biochemical testing, antibiotic resistance profiling, and PCR to detect typical 26 
virulence genes, ß lactamase and Class 1 Integron associated genes. Serotyping was 27 
performed on isolates positive for virulence genes. E. coli was identified from 103 samples, 28 
  
 2 
with verotoxin genes present in 7 E. coli isolates. Of these 7 isolates, 5 were resistant to five 1 
or more antibiotics. The isolate resistant to 9 antimicrobials contained a Class 1 Integron 2 
structure. Serotyping identified 7 separate VTEC, O2:H27, O26:H11, O63:H-, O148:H8, 3 
O149:H1, O174:H21 and ONT:H25. Six of these VTEC have been previously associated 4 
with human disease, however with the exception of O26:H11, these serotypes have been 5 
rarely reported worldwide. Increased surveillance is required to determine the prevalence of 6 
these and other non-O157 VTEC. The presence of multi-antibiotic resistance in these isolates 7 
is of concern, and the overall implications for public health must be ascertained. 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
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1. Introduction 1 
Since the emergence of verotoxigenic E. coli (VTEC) as human pathogens, contamination of 2 
foods of animal origin has been a major public health concern. Cattle are considered the 3 
main reservoir of VTEC, with infection associated with the consumption of contaminated 4 
beef and beef products (Griffin and Tauxe, 1991, Elder et al., 2000) or direct contact with 5 
animals and animal faeces on the farm (Howie et al., 2003, Crump et al., 2003). VTEC can 6 
produce severe illness in humans, leading to this infection being listed as a notifable disease 7 
in all European countries (EU-Report, 2001, Sanco 2001). The virulence of VTEC can be 8 
characterized by the expression of genes for potent verotoxins (VT1 and VT2), genes for 9 
intimin production (eae), and hly gene. (Frankel et al., 1998, Donnenberg et al., 2001).   10 
In the US, Canada, United Kingdom and Japan, serotype O157 is predominately 11 
identified in VTEC-associated disease. Unlike other E. coli serotypes, VTEC O157:H7 do 12 
not ferment sorbitol and are β -glucuronidase negative. These unique properties make the 13 
identification of this strain on selective media, such as sorbitol MacConkey (SMAC), 14 
straightforward (Mora et al., 2004). Infections with strains from serogroups such as O26, 15 
O111, O103 and O145 are the most common non-O157 VTEC associated with illness in 16 
humans (Blanco et al., 2004a). However, non-O157 VTEC infections may be frequently 17 
overlooked as they are indistinguishable from normal intestinal coliforms on the routinely 18 
used SMAC. Information on the source of non-O157 VTEC strains and their potential role in 19 
human disease is thus limited and needs further examination.  20 
The present study compares the phenotypic and genotypic characteristics of unusual 21 
non-O157 VTEC strains, which were isolated from healthy cattle and soil.  22 
 23 
  
 4 
2. Materials and Methods 1 
2.1 Isolation and Identification of Isolates 2 
2.1.1 Collection of samples 3 
 Faeces and soil samples were collected from 6 unrelated farms in the months of July to 4 
November. One faeces sample (10 g) was taken from the rectum of each animal (n=108) 5 
while soil samples (20 g), were obtained once from 5 paddocks on the same farm (n=20). 6 
Each animal was sampled once. In accordance with EU regulations, none of the animals was 7 
given food that contained anti-microbial agents. The soil samples were obtained from 8 
paddocks, which were empty of cattle at the time of sampling, although they had been grazed 9 
previously. There was no known contact of personnel or animals between the farms. 10 
 11 
2.1.2 Enrichment of samples 12 
Faeces samples were enriched in mTSB broth, (Oxoid, UK) containing streptomycin 13 
sulphate (1000 g/ml) stomached in a Colworth Stomacher (Model BA 6024, A. J. Steward 14 
& Co.Ltd. London, UK), and incubated at 37°C for 24 h. Aliquots were plated onto sorbitol 15 
MacConkey agar (Oxoid, UK) containing streptomycin sulphate (1000 g/ml), (SMAC-16 
strep), and incubated at 37°C for 24 h. Following incubation, a single colony was taken from 17 
each sample and stored on cryoprotective beads at –20°C until required for biochemical and 18 
molecular testing (Protect, Technical Services Consultants, Lancashire, UK). The presence 19 
of any bacterial growth on the plates after enrichment was considered a positive sample.  20 
 21 
  
 5 
2.1.3 Phenotypic characterisation 1 
Each isolate was Gram stained and characterized using API 20E and API 50CH commercial 2 
kits according to manufacturers instructions (Biomerieux).  3 
 4 
2.1.4 Virulence determination 5 
 After resuscitation from storage beads, template DNA was prepared from a single colony of 6 
each isolate. DNA was purified from the culture with a DNeasy extraction kit (Qiagen, 7 
Crawley, UK). All isolates were screened for virulence factors commonly associated with 8 
VTEC, eae, hly, vt1 and vt2 genes using a multiplex PCR method (Paton and Paton, 1998). 9 
The presence of virulence genes was also confirmed by independent PCR analysis by the 10 
Laboratorio de Referencia de E. coli  (LREC, Lugo, Spain) (Blanco et al., 2004b). Isolates 11 
positive for one or more of these genes were also screened for the presence of the rfbO157 12 
gene (Paton and Paton, 1998) and fliCh7 gene (Fratamico et al., 2000). PCR products were 13 
separated by electrophoresis on a 2% agarose gel, stained with ethidium bromide and 14 
visualised under UV illumination. The PCR products of eaeA, hly, vt1 and vt2 genes were 15 
purified using a PCR purification kit (Nucleospin Extract 11, Machery-Nagel, Germany) and 16 
sequenced commercially in duplicate (MWG Biotech, Ebersberg, Germany). Sequences were 17 
initially compared with the current GenBank sequence
 
databases using the BLAST suite of 18 
programs (Altschul et al., 1997). ClustalW amino
 
acid sequence alignments were produced 19 
for comparison online at http://www.ebi.ac.uk/clustalw.  20 
 21 
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2.1.5 Toxin production 1 
Isolates positive for vt1 or vt2 genes following PCR were tested for verotoxin production, 2 
using the commercial ELISA Premier-VTEC kit according to the manufacturers instructions 3 
(Meridian, Bioscience). 4 
 5 
2.1.6  Serotyping 6 
Serotyping was performed on isolates positive for virulence genes. The determination of O 7 
and H antigens was carried out by the LREC, (Lugo, Spain) as previously described, (Guinée 8 
et al., 1981) employing all available O (O1-O185) and H (H1-H56) antisera. All antisera 9 
were obtained and absorbed with the corresponding cross-reacting antigens to remove the 10 
nonspecific agglutinins. The O antisera were produced in the LERC and the H antisera were 11 
obtained from the Statens Serum Institute (Copenhagen, Denmark). 12 
2.2 Antibiotic susceptibility testing 13 
 14 
2.2.1 Phenotypic characterisation 15 
 Isolates positive for virulence genes, were examined for susceptibility to 12 antibiotics using 16 
the Bauer – Kirby disc diffusion method (Bauer et al., 1966). The following discs (Oxoid, U. 17 
K.) were used: ampicillin 10g, kanamycin 30g, cefixime 5g, cefaclor 30g, streptomycin 18 
10g, trimethoprim 5g, nalidixic acid 30g, compound sulphonamides 300g, 19 
chloramphenicol 30g, tetracycline 30g, ciprofloxacin 5g and moxalactam 30g .E. coli 20 
strain ATCC 25922 and S. aureus strain ATCC 25923 were used for quality control. (Oxoid , 21 
UK). After incubation, the diameter (in millimeters) of the zone of inhibition of each 22 
antibiotic was measured.  Isolates were classed as sensitive or resistant to each antibiotic 23 
according to Committee for Laboratory Standards Institute (CLSI) guidelines (NCCLS, 24 
2003).  25 
  
 7 
2.2.2 -lactamase and Class 1 Integron associated genes 1 
Template DNA from seven serotyped isolates was examined by PCR for several -lactamase 2 
(bla) encoding genes including; tem, carb, shv, oxa and ctx, as described previously 3 
(Wichard, 2005; Henriques et al. 2006; Batchelor et al. 2005, Pomba et al. 2006).  Variable 4 
regions containing the gene cassette(s) associated with class 1 integron structures were 5 
amplified, as described previously (O’Mahony et al. 2005).  The genes mapping to the 5’- 6 
and 3’-conserved structures of class 1 integrons, were also identified by PCR.    7 
 8 
2.2.3 DNA sequence analysis of Gene Cassettes  9 
Amplicons of interest were extracted directly from agarose gels using a QIAGEN gel 10 
extraction kit (QIAGEN, West Sussex, UK).  The recovered DNA fragment of interest was 11 
purified and quantified (as described above) prior to being sequenced commercially (Qiagen, 12 
Hilden, Germany).   Sequence text files were subsequently obtained and used to search the 13 
current GenBank databases using the BLAST suite of programs (Altschul et al., 1997).  14 
CLUSTALW amino acid sequence alignments were produced for comparison (Thompson et 15 
al., 1994). 16 
 17 
 18 
3. Results 19 
From 128 samples collected, 103 isolates were obtained which grew on SMAC-strep, 20 
covering the plate with a sorbitol fermenting (pink), mucoid growth. Each sample was 21 
individually sub-cultured onto SMAC-strep from which a single colony was taken for 22 
subsequent testing. Upon subculturing, large (2 mm diameter), round, mucoid colonies were 23 
observed and Gram-negative rod-shaped bacteria were identified following staining. All 24 
  
 8 
isolates were negative for Voges-Proskaur, hydrogen sulfide, citrate, oxidase and urease 1 
production and were positive for indole and fermented glucose, mannitol and sorbitol. The 2 
isolates were confirmed as E. coli following analysis of API 20E and API 50CH strip results. 3 
The API results were confirmed by PCR amplification of the 16S rRNA gene (data not 4 
shown).  5 
3.1 Virulence determination 6 
 From the 103 E. coli isolates tested, 7 were positive for the presence of vt1 or vt2 genes as 7 
presented in Table 1. Of these isolates, 4 were detected from cattle in Farm A, one from soil 8 
in Farm A and 2 isolates were detected from cattle faeces taken in Farms B and D. All 7 9 
isolates were negative for the presence of the rfbO157 and fliCh7 genes. Two isolates of were 10 
also identified positive for the presence of eae and hly genes.  Both isolates were serotyped 11 
as O123:H2. However as these isolate did not contain vt gene they are not included in the 12 
data presented in this paper.   13 
3.2  PCR product sequencing 14 
 Isolates obtained from animals 92 and 80 were not included in the PCR product sequencing 15 
analysis as either the vt1 gene was lost following storage (isolate 92) or the isolate could not 16 
be resuscitated (isolate 80).  BLAST searches showed that PCR products from positive vt1, 17 
vt2, hly and eaeA reactions were homologus to similar sequences in known bacteria carrying 18 
these genes. Deduced amino acid sequences from each PCR product were compared with 19 
selected known bacteria using ClustalW. The alignment demonstrated a similar amino acid 20 
homology across the regions examined. In summary it can be stated that the genes for vt1, 21 
vt2, eae and hly were present in the isolates examined. 22 
  
 9 
3.3 Verotoxin production 1 
Verotoxin production was confirmed for each isolate positive for the presence of vt1 or vt2 2 
gene. 3 
3.4 Serotyping 4 
 Serotyping was performed and 7 different VTEC serotypes were identified; O2:H27, 5 
O149:H1, O26:H11, O63:H-, O148:H8 and O174:H25 with one untypeable serotype 6 
ONT:H25 (Table 1). 7 
 8 
3.5 Antibiotic susceptibility 9 
Multi drug resistance (the resistance to three or more different antibiotic classes) was 10 
demonstrated in 5 of the 7 isolates. The AR profiles (Table 1) show that some of the isolates 11 
share a common resistance pattern. Serotype O174:H21 obtained from Farm D was resistant 12 
to the same 5 antibiotics as serotypes O2:H27 and O26:H11 isolated from Farm A. 13 
 14 
3.5.1  -lactamase and Class 1 Integron associated genes 15 
The bla-TEM gene was present in all 7 of the VTEC isolates with the exception of isolate 50 16 
and 84.  None of the other bla genes tested were found to be present.  E. coli O63:H- was the 17 
only strain found to contain complete class 1 integron structures. The integrase1 (int1), 18 
quaternary ammonium compound resistance (qacDE1), and sulphonamide resistance (sull) 19 
genes in addition to 4 gene cassettes (of sizes including1.0, 1.2, 1.6 kb) were detected after 20 
PCR. 21 
 22 
3.5. DNA sequence analysis of gene cassettes  23 
  
 10 
Sequence analysis of two gene cassettes 1.0 kb and 1.2 kb (Accession numbers EU 938126 1 
and EU938125) amplified from the E. coli O63:H-, gave 100% sequence identity to the 2 
aadA1 gene in E. coli.  The remaining gene 1.6 kb gene cassette (Accession No. EU938127) 3 
contained two ORF’s in the classical ‘head-to-tail’ orientation, with complete identity to a 4 
dfr1 gene and aadA1 gene in E. coli. The aadA1 (adenyltransferase) gene confers 5 
aminoglycoside resistance and the dfr (dihydrofolate reductase) gene confers trimethoprim 6 
resistance. 7 
 8 
 9 
  10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
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4. Discussion 1 
This study reports on the isolation of multiple VTEC serotypes from cattle faeces and 2 
soil. Of 103 antibiotic AR E. coli isolates in this study, 7 verotoxigenic serotypes, were 3 
identified. To detect whether these VTEC had been previously reported, a reference list 4 
was used which summarises published data on the serotypes and origin of non-O157 5 
VTEC up to 2003 (www.microbionet.com.au/vtectable.htm), in addition to a list of 6 
VTEC reported from the E. coli reference lab in Lugo, Spain 7 
(http://www.lugo.usc.es/ecoli/). Comparison with these, suggest that the serotypes found 8 
in the current study have been rarely reported previously, with the exception of O26:H11. 9 
Serotype O63:H- has never been reported from any source.  10 
In contrast to E. coli O157:H7, the identification of non–O157 VTEC is complex, 11 
with no obvious characteristics to consistently distinguish them from other E. coli 12 
serotypes.. In the present study, two of the seven serotypes detected, were obtained from 13 
farms remote from each other, where just six and four animals were sampled. This is in 14 
contrast to previous reports where extensive sampling and screening of multiple coliform 15 
colonies were obtained in order to isolate different serotypes. Beutin et al. (1997), 16 
examined 114 faeces samples from 19 cattle, and isolated 11 VTEC serotypes.  In a 17 
VTEC prevalence study in Japan, faecal samples were taken from 358 animals and 20 18 
coliform colonies per sample were tested for vt encoding genes, revealing 25 different 19 
serotypes (Kobayashi et al., 2001).  20 
In the present study all of the isolates fermented sorbitol and therefore would be 21 
overlooked if non-sorbitol fermenting colonies only were selected, as is usual with 22 
routine methods. The fact that these isolates are resistant to a number of anti-microbial 23 
  
 12 
agents may aid their detection in future studies by supplementing selective media with 1 
the appropriate anti-microbials. It should be noted, however, that as the methodology in 2 
the current study selected for streptomycin resistant VTEC only, a different protocol may 3 
have detected additional, non AR VTEC isolates. The results from the current study 4 
suggest that the prevalence and variety of non-O157 VTEC in food animals may be 5 
grossly underestimated, with the lack of standardised methods leading to difficulty in 6 
ascertaining the prevalence of these and other unidentified VTEC serotypes present in 7 
cattle and the food chain. 8 
The acquisition of verotoxin genes by enteric bacteria is well documented and the 9 
horizontal transmission of virulence factors has been crucial to the emergence of VTEC 10 
as important pathogens (Moxon et al., 1994). The isolates identified in this study 11 
contained many virulence factors that are associated with human disease and serotypes 12 
O2:H27, O149:H1, ONT:H25, O148:H8 and O174:H21 have been each been identified 13 
as infrequent human pathogens from several countries in Europe and North America. 14 
Verotoxin (VT) production was confirmed in just six of seven isolates as a vt gene was 15 
lost from serotype ONT:H25 following longterm storage (9 months). The loss of vt gene-16 
carrying phages has been previously reported following storage and cultivation of E. coli 17 
O157:H7 and non O157 isolates (Iguchi et al., 2002, Murase et al., 1999).   18 
The production of VT2 alone is associated with more serious clinical disease 19 
(Ostroff et al., 1989, Boerlin et al., 1999) and this toxin was produced by three strains in 20 
the current study, including serotype O174:H21, which has been previously associated 21 
with HUS.  Additional virulence factors associated with increased human pathogenicity 22 
were determined in five of the nine isolates. The eae gene was identified in two isolates 23 
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and serotypes carrying this gene have been linked with severe illness, such as 1 
haemorrhagic colitis and HUS (Oswald et al., 2000). The newly identified serotype 2 
O63:H- produced VT1 and contained hly and eae genes indicating that this serotype has 3 
the potential to be pathogenic to humans. The VTEC strains identified in the present 4 
study contain the necessary virulence genes required to cause human disease, and must be 5 
considered as potential pathogens that could be involved in future outbreaks of 6 
haemorrhagic colitis and HUS. Screening for these and other serotypes should be carried 7 
out in suspect clinical cases from which E. coli O157 is not isolated.  8 
E. coli are a rapidly evolving species capable of developing new pathogenic 9 
variants (Donnenberg et al., 2001).  LeClerc et al., (1996) reported that 1% of E. coli 10 
O157:H7 serotypes had spontaneous rates of mutation that were 1,000 fold higher than 11 
those of typical E. coli.  This ability to hyper-mutate may lead to the acquisition of 12 
virulence genes and development of other properties, such as antibiotic resistance, that 13 
increase bacterial diversity thus conferring a competitive advantage. Recently increasing 14 
numbers of multi-resistant VTEC have been isolated from humans, cattle and food 15 
(vonMüffling et al, 2007, Mora et al., 2005.) The findings of the current study indicate 16 
that the VTEC serotypes were simultaneously resistant to several anti-microbial classes, 17 
including penicillins, aminoglycosides, tetracyclines, sulphonamides and fluroquinolones 18 
with strain O63:H- resistant to 9 antibiotics. Multiple antibiotic resistance may be 19 
acquired through mobile genetic elements such as plasmids, transposons and Class 1 20 
integrons, (Mora et al., 2005, Singh et al., 2005), or due to the presence of 21 
overexpression from chromosomally encoded multi-drug efflux pumps (Poole, 2004). A 22 
complete class I integron structure was detected in strain O63:H and the bla-TEM gene, 23 
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which is generally plasmid encoded, was present in all isolates, suggesting the potential 1 
horizontal transfer of antibiotic resistance to other bacteria. Although anti-microbial 2 
treatment of VTEC infection is not recommended due to the potential for verotoxin 3 
release (Wong et al., 2000) the development of multiple resistant VTEC is nevertheless a 4 
development that public health professionals must note. It is unknown whether these AR 5 
serotypes have always been present, with a recent increase in prevalance in response to 6 
an unknown environmental stimulus. Future work characterizing the potential for 7 
resistance transfer from these isolates is critical to ascertain the significance of multiple 8 
antibiotic resistance in these pathogens. 9 
The identification of rare non-O157, multiply antibiotic resistant VTEC in this 10 
study is of concern. Findings from the current study suggest that targeted sampling and 11 
method development utilizing the antibiotic resistant characteristics may reveal many 12 
more of these serotypes in the bovine population and possibly elsewhere. Antibiotic 13 
resistant E. coli are known to be disseminated through the food chain, (Johnson et al., 14 
2005, DeFrancesco et al., 2004) therefore the bacteria from this study may represent a 15 
new group of clinically significant food-borne pathogens. This data highlights the need 16 
for increased monitoring for the presence of non–O157 VTEC in cattle and humans in 17 
addition to monitoring the level of antimicrobial resistance in order to ascertain the 18 
potential public health risk of these emerging strains. 19 
 20 
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